Results 201 to 204 of about 42,835 (204)

Dasatinib sensitizes KRAS-mutant colorectal cancer tumors to cetuximab

Nature Reviews Clinical Oncology, 2011
exaly  

Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors

Cancer Treatment Reviews, 2010
exaly  

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Annals of Oncology, 2016
exaly  

Dasatinib in Chronic Myelogenous Leukemia

New England Journal of Medicine, 2006
exaly